Check out our most popular compounded medications! Get Started
Oxybutynin Chloride 8% Topical Gel is a semisolid formulation dispensed through a pump mechanism. This allows for easy and precise application on the skin, providing targeted treatment for conditions such as Overactive Bladder, Urge Incontinence, Nocturnal Enuresis, Neurogenic Detrusor Overactivity, and Interstitial Cystitis. The gel-like consistency aids in the absorption of active ingredients.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Oxybutynin Chloride 8% Topical Gel is a prescription medication specifically designed to address various bladder-related conditions. These include overactive bladder, urinary incontinence, nocturnal enuresis, urge incontinence, and detrusor instability. This semisolid formulation is dispensed through a pump mechanism, which allows for easy and precise application on the skin. The active ingredients in the gel are absorbed through the skin, targeting the treatment area directly.
The mechanism of action of Oxybutynin Chloride 8% Topical Gel involves blocking certain nerve impulses that trigger bladder contractions. By doing so, it helps to decrease the frequency of bladder contractions, thereby improving bladder control.
While Oxybutynin Chloride 8% Topical Gel is generally well tolerated, some common side effects may occur. These can include skin irritation, dry mouth, and headaches. It is important for patients to consult with their healthcare provider or pharmacist if they have any questions or concerns about using this medication. They can provide comprehensive information about the medication's use, potential side effects, and how to manage them.
At Bayview Pharmacy, our team of compounding pharmacists has extensive experience and expertise in preparing Oxybutynin Chloride 8% Topical Gel. We are committed to providing high-quality compounded medications tailored to meet individual patient needs. If you have any questions about this formulation or how it can help manage your condition, please do not hesitate to contact us. We are here to assist you in your healthcare journey.
Oxybutynin Chloride 8% Topical Gel is a potent therapeutic option for managing conditions such as Overactive Bladder, Urinary Incontinence, Nocturnal Enuresis, Urge Incontinence, and Detrusor Instability. This unique formulation functions by inhibiting the action of acetylcholine, a neurotransmitter that triggers bladder muscle contractions. By doing so, it effectively reduces the frequency and urgency of urination, as well as the volume of urine leakage.
However, it is crucial to be aware that Oxybutynin Chloride 8% Topical Gel is contraindicated in patients with glaucoma, urinary retention, or uncontrolled narrow-angle glaucoma. It is also not suitable for patients with a known hypersensitivity to oxybutynin or any of the ingredients in the formulation. Patients are advised to refrain from activities requiring alertness, such as driving or operating machinery, until they fully understand how the medication influences them.
It's also worth noting that Oxybutynin Chloride 8% Topical Gel may cause side effects such as dry mouth, constipation, and blurred vision. If you have any queries about how this formulation can assist in treating Overactive Bladder, Urinary Incontinence, Nocturnal Enuresis, Urge Incontinence, and Detrusor Instability, please do not hesitate to get in touch.
Oxybutynin Chloride 8% Topical Gel is a specialized prescription medication primarily used to manage conditions such as Overactive Bladder, Urinary Incontinence, Nocturnal Enuresis, Urge Incontinence, and Detrusor Instability. This semisolid formulation is designed to be dispensed through a pump mechanism, which allows for easy and precise application directly onto the skin of the affected area. The active ingredient, Oxybutynin Chloride, works by blocking certain nerve impulses that trigger bladder contractions, thereby reducing the frequency of these contractions and improving overall bladder control.
The gel is typically applied once daily, preferably in the morning, to clean, dry skin. It is crucial to avoid contact with the eyes, mouth, and other mucous membranes during application. In case of accidental contact, the area should be thoroughly rinsed with water. Additionally, it is recommended to wash your hands after applying the gel to prevent accidental transfer to other areas.
While Oxybutynin Chloride 8% Topical Gel is generally well-tolerated, some users may experience common side effects such as dry mouth, headache, dizziness, and skin irritation. If you experience any of these side effects or have any concerns, it is important to contact your healthcare provider for advice. For any queries regarding the use of Oxybutynin Chloride 8% Topical Gel, please do not hesitate to reach out for further information.
Oxybutynin Chloride 8% Topical Gel is a semisolid formulation of the active ingredient Oxybutynin Chloride. It is dispensed through a pump mechanism for easy and precise application on the skin.
The gel is designed for targeted treatment or absorption of active ingredients. When applied to the skin, the active ingredient, Oxybutynin Chloride, is absorbed into the body to exert its therapeutic effects.
The gel should be applied to the skin as directed by your healthcare provider. The pump mechanism allows for easy and precise application.
It's important to follow your healthcare provider's instructions on where to apply the gel. Some areas of the body may absorb the medication more than others, which could lead to increased side effects.
If you miss a dose, apply it as soon as you remember. If it's close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not apply extra gel to make up for a missed dose.
Side effects can include dry mouth, constipation, dizziness, and blurred vision. If you experience any severe or persistent side effects, contact your healthcare provider immediately.
Always inform your healthcare provider about all the medications you are currently taking, including over-the-counter drugs and supplements. Some medications may interact with Oxybutynin Chloride, affecting its effectiveness or causing side effects.
Do not stop using the medication without consulting your healthcare provider, even if you feel better. Stopping the medication abruptly may cause your symptoms to return or worsen.
Store the gel at room temperature, away from heat and direct light. Do not freeze. Keep out of reach of children and pets.
If you suspect an overdose, seek immediate medical attention. Symptoms of an overdose may include severe dizziness, fainting, or seizures.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
